复发性脑膜瘤中不存在BRAF V600点突变。 - Suppr

BRAF V600 point mutation is not present in relapsing meningioma.

作者信息

Forest Fabien, Yvorel Violaine, Vassal François, Trombert Béatrice, Dumollard Jean-Marc, Nuti Christophe, Péoc'h Michel

出版信息

Clin Neuropathol. 2015 May-Jun;34(3):164-5. doi: 10.5414/NP300836.

DOI:10.5414/NP300836

PMID:25817073

Abstract

摘要

相似文献

BRAF V600 point mutation is not present in relapsing meningioma.

Clin Neuropathol. 2015 May-Jun;34(3):164-5. doi: 10.5414/NP300836.

Evolution to malignancy: A genetic stepwise study of tumor suppressor genes loss in a recurrent meningioma.

Clin Neuropathol. 2015 Jul-Aug;34(4):237-9. doi: 10.5414/NP300839.

Metastatic rhabdoid meningioma with BRAF V600E mutation and good response to personalized therapy: case report and review of the literature.

Pediatr Hematol Oncol. 2015 Apr;32(3):207-11. doi: 10.3109/08880018.2014.936058. Epub 2014 Aug 12.

Real-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemia.

Hematol Oncol. 2012 Dec;30(4):190-3. doi: 10.1002/hon.1023. Epub 2011 Dec 22.

Clear cell meningiomas: three case reports with genetic characterization and review of the literature.

Neurosurgery. 2010 Sep;67(3):E870-1; discussion E871. doi: 10.1227/01.NEU.0000374857.06732.CD.

[Familial incidence of multiple, mainly spinal meningiomas].

Nervenarzt. 1992 Apr;63(4):244-6.

BRAF V600E mutation in two distinct meningeal melanocytomas associated with a nevus of Ota.

J Clin Oncol. 2014 Jul 10;32(20):e72-5. doi: 10.1200/JCO.2013.48.8718. Epub 2014 Feb 3.

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.

Clin Endocrinol (Oxf). 2006 Sep;65(3):364-8. doi: 10.1111/j.1365-2265.2006.02605.x.

Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer.

Ann Surg Oncol. 2011 Dec;18(13):3566-71. doi: 10.1245/s10434-011-1781-5. Epub 2011 May 19.

A novel BRAF::PTPRN2 fusion in meningioma: a case report.

Acta Neuropathol Commun. 2023 Dec 8;11(1):194. doi: 10.1186/s40478-023-01668-w.

引用本文的文献

New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses.

Oncotarget. 2019 Sep 17;10(53):5549-5559. doi: 10.18632/oncotarget.27178.

Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAF(V600E) Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib.

J Neuropathol Exp Neurol. 2015 Oct;74(10):960-9. doi: 10.1097/NEN.0000000000000240.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

BRAF V600 point mutation is not present in relapsing meningioma.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

BRAF V600 point mutation is not present in relapsing meningioma.

作者信息

出版信息